N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB

Abstract: It is now well established that the formation of free radicals and oxidative stress‐induced neuronal cell death can be involved in various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. The pineal hormone melatonin has been suggested to be a neuroprotective antioxidant. To better understand the molecular mechanism of this activity, we compared the ability of melatonin and its precursor, N‐acetyl‐serotonin (normelatonin), to protect human neuroblastoma SK‐N‐MC cells and primary cerebellar granular neurons against oxidative stress. We found that normelatonin and melatonin have differential neuroprotective effects depending on the neuronal cell type. Normelatonin was more protective against hydrogen peroxide (H2O2) and glutamate‐induced cell death in SK‐N‐MC cells compared to melatonin which was more effective to protect primary cerebellar granular neurons against the toxicity of H2O2, glutamate and N‐methyl‐D‐aspartate when compared to normelatonin. At the molecular level, we tested the capacity of normelatonin and melatonin to inhibit the oxidative stress‐induced NF‐κB activation in both neuronal systems. Whereas normelatonin was more potent in the suppression of the activation of NF‐κB by H2O2 in SK‐N‐MC cells compared to melatonin, no apparent differences in the extent of suppression could be detected in primary neurons. Normelatonin's and melatonin's neuroprotective activity in SK‐N‐MC neuroblastoma cells may be mediated by the suppression of NF‐κB activation.

[1]  C. Behl.  Amyloid β-protein toxicity and oxidative stress in Alzheimer’s disease , 1997, Cell and Tissue Research.

[2]  M. Uhr,et al.  Neuroprotective potential of aromatic alcohols against oxidative cell death , 1997, FEBS letters.

[3]  D. Peterson,et al.  Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction , 1997, Journal of neurochemistry.

[4]  F. Stirpe,et al.  Toxicity of ricin and volkensin, two ribosome‐inactivating proteins, to microglia, astrocyte, and neuron cultures , 1997, Glia.

[5]  M. Ciotti,et al.  Glutamate Neurotoxicity in Rat Cerebellar Granule Cells: A Major Role for Xanthine Oxidase in Oxygen Radical Formation , 1997, Journal of neurochemistry.

[6]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[7]  F. Holsboer,et al.  Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.

[8]  R. Reiter,et al.  Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide , 1997, The Journal of Neuroscience.

[9]  Vijay R Baichwal,et al.  Apoptosis: Activate NF-κB or die? , 1997, Current Biology.

[10]  J. Behr,et al.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. , 1996, Gene therapy.

[11]  M. Memo,et al.  Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.

[12]  M. Meltz,et al.  EFFECT OF MELATONIN ON NF‐κB DNA‐BINDING ACTIVITY IN THE RAT SPLEEN , 1996 .

[13]  F. Lezoualc’h,et al.  Melatonin prevents oxidative stress‐induced cell death in hippocampal cells , 1996, Neuroreport.

[14]  H. Manev,et al.  In vitro and in vivo protection against kainate‐induced excitotoxicity by melatonin , 1996, Journal of pineal research.

[15]  R. Reiter,et al.  Melatonin Its intracellular and genomic actions , 1996, Trends in Endocrinology & Metabolism.

[16]  M. Meltz,et al.  The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. , 1995, Biochemistry and molecular biology international.

[17]  P. Baeuerle,et al.  Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Mattson,et al.  Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons , 1995, Journal of neurochemistry.

[19]  R. Reiter.  Functional Pleiotropy of the Neurohormone Melatonin: Antioxidant Protection and Neuroendocrine Regulation , 1995, Frontiers in Neuroendocrinology.

[20]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. A. Weil,et al.  An in vitro EPR study of the free-radical scavenging actions of the lazaroid antioxidants U-74500A and U-78517F. , 1995, Free radical biology & medicine.

[22]  R. Reiter,et al.  Melatonin stimulates brain glutathione peroxidase activity , 1995, Neurochemistry International.

[23]  H. Manev,et al.  Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-d-aspartate excitotoxicity , 1995, Experimental Neurology.

[24]  R. Reiter,et al.  A review of the evidence supporting melatonin's role as an antioxidant , 1995, Journal of pineal research.

[25]  R. Balázs,et al.  Growth conditions differentially modulate the vulnerability of developing cerebellar granule cells to excitatory amino acids , 1994, Brain Research.

[26]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[27]  C. Olanow.  A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[28]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[29]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Bockaert,et al.  NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.

[31]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[32]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[33]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[34]  E. Costa,et al.  Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-D-aspartate. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[36]  T. Murphy,et al.  Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress , 1989, Neuron.

[37]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[38]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[39]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[40]  P. Sinet,et al.  Hydrogen Peroxide Production by Rat Brain In Vivo , 1980, Journal of neurochemistry.

[41]  F. Lezoualc’h,et al.  Transcription factor NF-κB: friend or foe of neurons? , 1998, Molecular Psychiatry.

[42]  S. Lipton.  Janus faces of NF-κB: Neurodestruction versus neuroprotection , 1997, Nature Medicine.

[43]  G Nistico,et al.  Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. , 1995, Life sciences.

[44]  R. Reiter,et al.  Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. , 1994, Life sciences.

[45]  E. Hall,et al.  Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. , 1989, Free radical biology & medicine.